Promoting Metabolic and Endocrine Health in Children and Adolescents Treated with Antipsychotics
(Accreditation Expired)
Faculty: Christoph U. Correll, MD | Robert L. Findling, MD | Linmarie Sikich, MD
CE credit hour: 1.0
Clinicians need to carefully consider the overall impact of weight gain, associated metabolic issues, and endocrine abnormalities associated with antipsychotic treatment.  Several recent epidemiological studies have documented a sharp increase in the prescription of second-generation antipsychotics for children and adolescents with psychotic and non-psychotic conditions. A thorough understanding of the different adverse effect profiles of second-generation antipsychotic agents is required to effectively manage the mental and physical health of this vulnerable patient population.

Closing the Gap to Adherence in Schizophrenia: Putting Evidence Into Practice
(Accreditation Expired)
Faculty: John M. Kane, MD
CME credit hour: 1.0
Discontinuation of treatment has been identified as a grave concern and obstacle to optimal outcomes in patients with schizophrenia, and a major contributor to discontinuation of treatment is lack of patient adherence to treatment. To improve compliance among patients, psychiatrists first must identify noncompliant patients and then institute a treatment plan that will take into consideration the barriers to compliance that many patients face. Clinicians also must examine their own barriers to optimizing patient adherence. Finally, clinicians must have strategies for monitoring compliance on an ongoing basis and in a way that patients will accept. This activity is intended to address each of these items through expert commentary provided from a highly respected psychiatrist in schizophrenia.

Benefits and Risks of Antipsychotic Medication: A Focus on Sedation (Accreditation Expired)
Faculty: John M. Kane, MD | Christoph U. Correll, MD | Del D. Miller, PharmD, MD
CME credit hour: 1.0
In the management of psychotic episodes, the implications of sedation differ depending upon the intervention stage. Sedation that is advantageous in acute intervention may interfere with therapy in later stages. Historically, the sedation associated with older antipsychotic agents was considered a sign of efficacy. Recent studies, however, show that newer antipsychotic agents effectively control both psychosis and acute agitation with minimal sedation. Use of these agents may achieve acute control while allowing the patient to participate in therapeutic and normal daily activities. In this program, our experts will review the role of sedation in the management of psychotic episodes, from acute stabilization through maintenance.

Diagnosing & Treating Atypical Depression (Accreditation Expired)
Faculty: Michael E. Thase, MD | Jonathan W. Stewart, MD | John M. Zajecka, MD
CME Credit hour: 1.0
Join Dr. Michael Thase, Dr. Jonathan Stewart, and Dr. John Zajecka, as they discuss the biologic profile, diagnosis, and treatment of atypical depression. These three distinguished panelists share their clinical experiences and suggest strategies for diagnosing and treating patients with atypical depression.

All information content within shall be considered confidential property of ArcMesa Educators, LLC
and should not be disclosed or redistributed to third parties without express permission.